IOVANCE BIOTHERAPEUTICS, INC. Loss Contingency, New Claims Filed, Number
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Loss Contingency, New Claims Filed, Number of 2 item as of 2025-05-15, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2026-08-06
- 2025-05-15: Loss Contingency, New Claims Filed, Number 2.00 item.
| Period end | Loss Contingency, New Claims Filed, Number |
|---|---|
| 2025-05-15 | 2.00 item 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |